Tags

Type your tag names separated by a space and hit enter

Specific caspase inhibitor Q-VD-OPh prevents neonatal stroke in P7 rat: a role for gender.
J Neurochem. 2007 Feb; 100(4):1062-71.JN

Abstract

Hypoxia-ischaemia in the developing brain results in brain injury with prominent features of apoptosis. In the present study, a third generation dipeptidyl broad-spectrum caspase inhibitor, quinoline-Val-Asp(Ome)-CH2-O-phenoxy (Q-VD-OPh), was tested in a model of unilateral focal ischaemia with reperfusion in 7-day-old rats. Q-VD-OPh (1 mg/kg, i.p.) reduced cell death, resulting in significant neuroprotection at 48 h of recovery (infarct volume of 12.6 +/- 2.8 vs. 24.3 +/- 2.2%, p = 0.006). The neuroprotective effects observed at 48 h post-ischaemia hold up at 21 days of survival time and attenuate neurological dysfunction. Analysis by gender revealed that females were strongly protected (6.7 +/- 3.3%, p = 0.006), in contrast to males in which there was no significant effect, when Q-VD-OPh was given after clip removal on the left common carotid artery. Immunoblot analysis demonstrated that Q-VD-OPh inhibits caspase 3 cleavage into its p17 active form and caspase 1 up-regulation and cleavage in vivo. Following ischaemia in P7 rats, males and females displayed different time course and pattern of cytochrome c release and active p17 caspase 3 during the first 24 h of recovery. In contrast, no significant difference was observed for caspase 1 expression between genders. These results indicate that ischaemia activates caspases shortly after reperfusion and that the sex of the animal may strongly influences apoptotic pathways in the pathogenesis of neonatal brain injury. The specificity, effectiveness, and reduced toxicity of Q-VD-OPh may determine the potential use of peptide-derived irreversible caspase inhibitors as promising therapeutics.

Authors+Show Affiliations

UMR-CNRS, Paris, France.No affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

Comparative Study
Journal Article
Research Support, Non-U.S. Gov't

Language

eng

PubMed ID

17166174

Citation

Renolleau, Sylvain, et al. "Specific Caspase Inhibitor Q-VD-OPh Prevents Neonatal Stroke in P7 Rat: a Role for Gender." Journal of Neurochemistry, vol. 100, no. 4, 2007, pp. 1062-71.
Renolleau S, Fau S, Goyenvalle C, et al. Specific caspase inhibitor Q-VD-OPh prevents neonatal stroke in P7 rat: a role for gender. J Neurochem. 2007;100(4):1062-71.
Renolleau, S., Fau, S., Goyenvalle, C., Joly, L. M., Chauvier, D., Jacotot, E., Mariani, J., & Charriaut-Marlangue, C. (2007). Specific caspase inhibitor Q-VD-OPh prevents neonatal stroke in P7 rat: a role for gender. Journal of Neurochemistry, 100(4), 1062-71.
Renolleau S, et al. Specific Caspase Inhibitor Q-VD-OPh Prevents Neonatal Stroke in P7 Rat: a Role for Gender. J Neurochem. 2007;100(4):1062-71. PubMed PMID: 17166174.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Specific caspase inhibitor Q-VD-OPh prevents neonatal stroke in P7 rat: a role for gender. AU - Renolleau,Sylvain, AU - Fau,Sébastien, AU - Goyenvalle,Catherine, AU - Joly,Luc-Marie, AU - Chauvier,David, AU - Jacotot,Etienne, AU - Mariani,Jean, AU - Charriaut-Marlangue,Christiane, Y1 - 2006/12/12/ PY - 2006/12/15/pubmed PY - 2007/4/11/medline PY - 2006/12/15/entrez SP - 1062 EP - 71 JF - Journal of neurochemistry JO - J Neurochem VL - 100 IS - 4 N2 - Hypoxia-ischaemia in the developing brain results in brain injury with prominent features of apoptosis. In the present study, a third generation dipeptidyl broad-spectrum caspase inhibitor, quinoline-Val-Asp(Ome)-CH2-O-phenoxy (Q-VD-OPh), was tested in a model of unilateral focal ischaemia with reperfusion in 7-day-old rats. Q-VD-OPh (1 mg/kg, i.p.) reduced cell death, resulting in significant neuroprotection at 48 h of recovery (infarct volume of 12.6 +/- 2.8 vs. 24.3 +/- 2.2%, p = 0.006). The neuroprotective effects observed at 48 h post-ischaemia hold up at 21 days of survival time and attenuate neurological dysfunction. Analysis by gender revealed that females were strongly protected (6.7 +/- 3.3%, p = 0.006), in contrast to males in which there was no significant effect, when Q-VD-OPh was given after clip removal on the left common carotid artery. Immunoblot analysis demonstrated that Q-VD-OPh inhibits caspase 3 cleavage into its p17 active form and caspase 1 up-regulation and cleavage in vivo. Following ischaemia in P7 rats, males and females displayed different time course and pattern of cytochrome c release and active p17 caspase 3 during the first 24 h of recovery. In contrast, no significant difference was observed for caspase 1 expression between genders. These results indicate that ischaemia activates caspases shortly after reperfusion and that the sex of the animal may strongly influences apoptotic pathways in the pathogenesis of neonatal brain injury. The specificity, effectiveness, and reduced toxicity of Q-VD-OPh may determine the potential use of peptide-derived irreversible caspase inhibitors as promising therapeutics. SN - 0022-3042 UR - https://www.unboundmedicine.com/medline/citation/17166174/Specific_caspase_inhibitor_Q_VD_OPh_prevents_neonatal_stroke_in_P7_rat:_a_role_for_gender_ L2 - https://doi.org/10.1111/j.1471-4159.2006.04269.x DB - PRIME DP - Unbound Medicine ER -